Seroepidemiology for Enteric Fever: Emerging Approaches and Opportunities

Abstract Safe and effective typhoid conjugate vaccines (TCVs) are available, but many countries lack the high-resolution data needed to prioritize TCV introduction to the highest-risk communities. Here we discuss seroepidemiology—an approach using antibody response data to characterize infection burden—as a potential tool to fill this data gap. Serologic tests for typhoid have existed for over a hundred years, but only recently were antigens identified that were sensitive and specific enough to use as epidemiologic markers. These antigens, coupled with new methodological developments, permit estimating seroincidence—the rate at which new infections occur in a population—from cross-sectional serosurveys. These new tools open up many possible applications for enteric fever seroepidemiology, including generating high-resolution surveillance data, monitoring vaccine impact, and integrating with other serosurveillance initiatives. Challenges remain, including distinguishing Salmonella Typhi from Salmonella Paratyphi infections and accounting for reinfections. Enteric fever seroepidemiology can be conducted at a fraction of the cost, time, and sample size of surveillance blood culture studies and may enable more efficient and scalable surveillance for this important infectious disease.

[1]  P. Teunis,et al.  Seroincidence of Enteric Fever, Juba, South Sudan , 2022, Emerging infectious diseases.

[2]  A. Azman,et al.  Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers , 2022, PLoS neglected tropical diseases.

[3]  I. Bogoch,et al.  Estimating typhoid incidence from community-based serosurveys: a multicohort study , 2022, The Lancet. Microbe.

[4]  G. Dougan,et al.  Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study. , 2021, The Lancet. Global health.

[5]  K. Neuzil,et al.  Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial , 2021, The Lancet. Global health.

[6]  R. Heyderman,et al.  Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children , 2021, The New England journal of medicine.

[7]  P. Teunis,et al.  Estimation of seroconversion rates for infectious diseases: Effects of age and noise , 2020, Statistics in medicine.

[8]  J. Keenan,et al.  Seroprevalence of antibodies against Chlamydia trachomatis and enteropathogens and distance to the nearest water source among young children in the Amhara Region of Ethiopia , 2020, medRxiv.

[9]  C. Parry,et al.  Redefining typhoid diagnosis: what would an improved test need to look like? , 2019, BMJ Global Health.

[10]  S. Baker,et al.  Ascertaining the burden of invasive Salmonella disease in hospitalised febrile children aged under four years in Blantyre, Malawi , 2019, PLoS neglected tropical diseases.

[11]  David L. Smith,et al.  The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet. Infectious diseases.

[12]  S. Baker,et al.  The Relationship Between Blood Sample Volume and Diagnostic Sensitivity of Blood Culture for Typhoid and Paratyphoid Fever: A Systematic Review and Meta-Analysis , 2018, The Journal of infectious diseases.

[13]  I. Bogoch,et al.  Plasma Immunoglobulin A Responses Against 2 Salmonella Typhi Antigens Identify Patients With Typhoid Fever , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Cano,et al.  A cross-sectional seroepidemiological survey of typhoid fever in Fiji , 2017, PLoS neglected tropical diseases.

[15]  F. Cutts,et al.  Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low‐ and middle‐income countries , 2016, Tropical medicine & international health : TM & IH.

[16]  D. Molina,et al.  Serodiagnosis of Acute Typhoid Fever in Nigerian Pediatric Cases by Detection of Serum IgA and IgG Against Hemolysin E and Lipopolysaccharide. , 2016, The American journal of tropical medicine and hygiene.

[17]  J. Y. Park,et al.  Revisiting typhoid fever surveillance in low and middle income countries: lessons from systematic literature review of population-based longitudinal studies , 2015, BMC Infectious Diseases.

[18]  J. Andrews,et al.  Diagnostics for invasive Salmonella infections: Current challenges and future directions. , 2015, Vaccine.

[19]  M. Levine,et al.  Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  M. Kretzschmar,et al.  A two-phase within-host model for immune response and its application to serological profiles of pertussis. , 2014, Epidemics.

[21]  S. Baker,et al.  Immunoproteomic Analysis of Antibody in Lymphocyte Supernatant in Patients with Typhoid Fever in Bangladesh , 2013, Clinical and Vaccine Immunology.

[22]  D. Huw Davies,et al.  Immune profiling with a Salmonella Typhi antigen microarray identifies new diagnostic biomarkers of human typhoid , 2013, Scientific Reports.

[23]  Y T H P van Duynhoven,et al.  Biomarker dynamics: estimating infection rates from serological data , 2012, Statistics in medicine.

[24]  J. Farrar,et al.  Kinetics of the Natural, Humoral Immune Response to Salmonella enterica Serovar Typhi in Kathmandu, Nepal , 2009, Clinical and Vaccine Immunology.

[25]  P. Teunis,et al.  Estimation of incidences of infectious diseases based on antibody measurements , 2009, Statistics in medicine.

[26]  S. Wai,et al.  Characterization of a Pore-Forming Cytotoxin Expressed by Salmonella enterica Serovars Typhi and Paratyphi A , 2002, Infection and Immunity.

[27]  L. Olopoenia,et al.  Widal agglutination test − 100 years later: still plagued by controversy , 2000, Postgraduate medical journal.

[28]  J. Wain,et al.  Value of a Single-Tube Widal Test in Diagnosis of Typhoid Fever in Vietnam , 1999, Journal of Clinical Microbiology.

[29]  J. Robbins,et al.  Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. , 1996, Vaccine.

[30]  J. Cross,et al.  Diagnostic value of a single, pre-treatment Widal test in suspected enteric fever cases in the Philippines. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.